Calico Life Sciences Announces Fosigotifator Granted Breakthrough Therapy Designation by the U.S. FDA for the Treatment of Vanishing White Matter Disease

fosigotifator (ABBV-CLS-7262) - AbbVie, Calico Life Sciences

Jun 23, 2026